{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:36:26Z","timestamp":1792092986108,"version":"4.4.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the STI2030-Major Projects","award":["No.2021ZD0201802"],"award-info":[{"award-number":["No.2021ZD0201802"]}]},{"name":"the Key Project of the National Natural Science Foundation of China","award":["U20A20354"],"award-info":[{"award-number":["U20A20354"]}]},{"name":"Beijing Brain Initiative from Beijing Municipal Science & Technology Commission","award":["Z201100005520016, Z201100005520017"],"award-info":[{"award-number":["Z201100005520016, Z201100005520017"]}]},{"name":"the grant from the Chinese Institutes for Medical Research","award":["CX23YZ15"],"award-info":[{"award-number":["CX23YZ15"]}]},{"name":"the National Key Scientific Instrument and Equipment Development Project","award":["31627803"],"award-info":[{"award-number":["31627803"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01694-x","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T15:05:16Z","timestamp":1739545516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pathway-based network medicine identifies novel natural products for Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Yumei","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"10284","key":"1694_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4.","journal-title":"Lancet"},{"issue":"3","key":"1694_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"A Cavalli","year":"2008","unstructured":"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem. 2008;51(3):347\u201372. https:\/\/doi.org\/10.1021\/jm7009364.","journal-title":"J Med Chem"},{"key":"1694_CR3","doi-asserted-by":"publisher","first-page":"846902","DOI":"10.3389\/fnagi.2022.846902","volume":"14","author":"SL Morgan","year":"2022","unstructured":"Morgan SL, Naderi P, Koler K, Pita-Juarez Y, Prokopenko D, Vlachos IS, et al. Most pathways can be related to the pathogenesis of Alzheimer\u2019s Disease. Front Aging Neurosci. 2022;14:846902. https:\/\/doi.org\/10.3389\/fnagi.2022.846902.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1694_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1568026622666220117105740","volume":"22","author":"R Kaur","year":"2022","unstructured":"Kaur R, Sood A, Lang DK, Arora R, Kumar N, Diwan V, et al. Natural products as sources of Multitarget compounds: advances in the development of Ferulic Acid as Multitarget Therapeutic. Curr Top Med Chem. 2022;22(5):347\u201365. https:\/\/doi.org\/10.2174\/1568026622666220117105740.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"1694_CR5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3233\/jad-171110","volume":"62","author":"TT Hou","year":"2018","unstructured":"Hou TT, Yang HY, Wang W, Wu QQ, Tian YR, Jia JP. Sulforaphane inhibits the generation of Amyloid-\u03b2 Oligomer and promotes spatial learning and memory in Alzheimer\u2019s Disease (PS1V97L) transgenic mice. J Alzheimers Dis. 2018;62(4):1803\u201313. https:\/\/doi.org\/10.3233\/jad-171110.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1694_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/jad-180126","volume":"64","author":"H Li","year":"2018","unstructured":"Li H, Jia J, Wang W, Hou T, Tian Y, Wu Q, et al. Honokiol alleviates cognitive deficits of Alzheimer\u2019s Disease (PS1V97L) transgenic mice by activating mitochondrial SIRT3. J Alzheimers Dis. 2018;64(1):291\u2013302. https:\/\/doi.org\/10.3233\/jad-180126.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1694_CR7","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1007\/s12035-022-02850-2","volume":"59","author":"D Lyu","year":"2022","unstructured":"Lyu D, Jia J. Cryptotanshinone attenuates Amyloid-\u03b2(42)-induced tau phosphorylation by regulating PI3K\/Akt\/GSK3\u03b2 pathway in HT22 cells. Mol Neurobiol. 2022;59(7):4488\u2013500. https:\/\/doi.org\/10.1007\/s12035-022-02850-2.","journal-title":"Mol Neurobiol"},{"key":"1694_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fphar.2017.00747","volume":"8","author":"J Fang","year":"2017","unstructured":"Fang J, Gao L, Ma H, Wu Q, Wu T, Wu J, et al. Quantitative and systems Pharmacology 3. Network-based identification of new targets for Natural products enables potential uses in Aging-Associated disorders. Front Pharmacol. 2017;8:747. https:\/\/doi.org\/10.3389\/fphar.2017.00747.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1694_CR9","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1021\/acs.jcim.7b00216","volume":"57","author":"J Fang","year":"2017","unstructured":"Fang J, Wu Z, Cai C, Wang Q, Tang Y, Cheng F. Quantitative and systems Pharmacology. 1. In Silico Prediction of Drug-Target interactions of Natural products enables new targeted Cancer therapy. J Chem Inf Model. 2017;57(11):2657\u201371. https:\/\/doi.org\/10.1021\/acs.jcim.7b00216.","journal-title":"J Chem Inf Model"},{"issue":"9\u201310","key":"1694_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","volume":"18","author":"JL Medina-Franco","year":"2013","unstructured":"Medina-Franco JL, Giulianotti MA, Welmaker GS, Houghten RA. Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today. 2013;18(9\u201310):495\u2013501. https:\/\/doi.org\/10.1016\/j.drudis.2013.01.008.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1694_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1694_CR12","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 2024;52(D1):D672\u20138. https:\/\/doi.org\/10.1093\/nar\/gkad1025.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1694_CR13","doi-asserted-by":"publisher","first-page":"D679","DOI":"10.1093\/nar\/gkad960","volume":"52","author":"A Agrawal","year":"2023","unstructured":"Agrawal A, Balc\u0131 H, Hanspers K, Coort SL, Martens M, Slenter DN, et al. WikiPathways 2024: next generation pathway database. Nucleic Acids Res. 2023;52(D1):D679\u201389. https:\/\/doi.org\/10.1093\/nar\/gkad960.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1694_CR14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"1694_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. https:\/\/doi.org\/10.1186\/1758-2946-6-13.","journal-title":"J Cheminform"},{"key":"1694_CR16","doi-asserted-by":"publisher","first-page":"7498525","DOI":"10.1155\/2020\/7498525","volume":"2020","author":"W Dan","year":"2020","unstructured":"Dan W, Liu J, Guo X, Zhang B, Qu Y, He Q. Study on Medication rules of Traditional Chinese Medicine against Antineoplastic Drug-Induced Cardiotoxicity Based on Network Pharmacology and Data Mining. Evid Based Complement Alternat Med. 2020;2020:7498525. https:\/\/doi.org\/10.1155\/2020\/7498525.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1694_CR17","doi-asserted-by":"publisher","first-page":"5530898","DOI":"10.1155\/2021\/5530898","volume":"2021","author":"S Hu","year":"2021","unstructured":"Hu S, Dan W, Liu J, Ha P, Zhou T, Guo X, et al. The Use of Traditional Chinese Medicine in Relieving EGFR-TKI-Associated Diarrhea based on Network Pharmacology and Data Mining. Evid Based Complement Alternat Med. 2021;2021:5530898. https:\/\/doi.org\/10.1155\/2021\/5530898.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1694_CR18","doi-asserted-by":"publisher","first-page":"964469","DOI":"10.3389\/fcimb.2022.964469","volume":"12","author":"X Yin","year":"2022","unstructured":"Yin X, Li J, Hao Z, Ding R, Qiao Y. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology. Front Cell Infect Microbiol. 2022;12:964469. https:\/\/doi.org\/10.3389\/fcimb.2022.964469.","journal-title":"Front Cell Infect Microbiol"},{"key":"1694_CR19","doi-asserted-by":"publisher","unstructured":"Sun X, Deng Y, Fu X, Wang S, Duan R, Zhang Y. AngIV-Analog Dihexa rescues cognitive impairment and recovers memory in the APP\/PS1 mouse via the PI3K\/AKT signaling pathway. Brain Sci. 2021;11(11). https:\/\/doi.org\/10.3390\/brainsci11111487.","DOI":"10.3390\/brainsci11111487"},{"issue":"2","key":"1694_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bioactmat.2020.08.017","volume":"6","author":"Y Han","year":"2021","unstructured":"Han Y, Gao C, Wang H, Sun J, Liang M, Feng Y, et al. Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice. Bioact Mater. 2021;6(2):529\u201342. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.08.017.","journal-title":"Bioact Mater"},{"key":"1694_CR21","doi-asserted-by":"publisher","unstructured":"Lopes Andrade AW, Dias Ribeiro Figueiredo D, Torequl Islam M, Viana Nunes AM, da, Concei\u00e7\u00e3o Machado K. da Concei\u00e7\u00e3o Machado K, Toxicological evaluation of the biflavonoid, agathisflavone in albino Swiss mice. Biomed Pharmacother. 2019;110:68\u201373. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.050","DOI":"10.1016\/j.biopha.2018.11.050"},{"issue":"10","key":"1694_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1179\/1743132815Y.0000000066","volume":"37","author":"H Yang","year":"2015","unstructured":"Yang H, Wang S, Yu L, Zhu X, Xu Y. Esculentoside A suppresses Abeta(1\u201342)-induced neuroinflammation by down-regulating MAPKs pathways in vivo. Neurol Res. 2015;37(10):859\u201366. https:\/\/doi.org\/10.1179\/1743132815Y.0000000066.","journal-title":"Neurol Res"},{"key":"1694_CR23","doi-asserted-by":"publisher","first-page":"154555","DOI":"10.1016\/j.phymed.2022.154555","volume":"109","author":"Z He","year":"2023","unstructured":"He Z, Zhang H, Li X, Tu S, Wang Z, Han S, et al. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer\u2019s disease. Phytomedicine. 2023;109:154555. https:\/\/doi.org\/10.1016\/j.phymed.2022.154555.","journal-title":"Phytomedicine"},{"key":"1694_CR24","doi-asserted-by":"publisher","first-page":"135016","DOI":"10.1016\/j.neulet.2020.135016","volume":"730","author":"Y Kong","year":"2020","unstructured":"Kong Y, Peng Q, Lv N, Yuan J, Deng Z, Liang X, et al. Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer\u2019s disease via activation of adenosine A(1) receptor. Neurosci Lett. 2020;730:135016. https:\/\/doi.org\/10.1016\/j.neulet.2020.135016.","journal-title":"Neurosci Lett"},{"key":"1694_CR25","doi-asserted-by":"publisher","first-page":"155408","DOI":"10.1016\/j.cyto.2020.155408","volume":"139","author":"SP Kamdi","year":"2021","unstructured":"Kamdi SP, Raval A, Nakhate KT. Phloridzin attenuates lipopolysaccharide-induced cognitive impairment via antioxidant, anti-inflammatory and neuromodulatory activities. Cytokine. 2021;139:155408. https:\/\/doi.org\/10.1016\/j.cyto.2020.155408.","journal-title":"Cytokine"},{"issue":"1","key":"1694_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13041-022-00948-1","volume":"15","author":"HJ Choi","year":"2022","unstructured":"Choi HJ, Park JH, Jeong YJ, Hwang JW, Lee S, Lee H, et al. Donepezil ameliorates A\u03b2 pathology but not tau pathology in 5xFAD mice. Mol Brain. 2022;15(1):63. https:\/\/doi.org\/10.1186\/s13041-022-00948-1.","journal-title":"Mol Brain"},{"key":"1694_CR27","doi-asserted-by":"publisher","DOI":"10.3791\/55718","author":"LM Lueptow","year":"2017","unstructured":"Lueptow LM. Novel object Recognition Test for the investigation of learning and memory in mice. J Vis Exp. 2017. https:\/\/doi.org\/10.3791\/55718. (126).","journal-title":"J Vis Exp"},{"key":"1694_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for Assessment of spatial working and reference memory in mice. Methods Mol Biol. 2019;1916:105\u201311. https:\/\/doi.org\/10.1007\/978-1-4939-8994-2_10.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"1694_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848\u201358. https:\/\/doi.org\/10.1038\/nprot.2006.116.","journal-title":"Nat Protoc"},{"issue":"1","key":"1694_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18(1):529. https:\/\/doi.org\/10.1186\/s12859-017-1934-z.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"1694_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"5","key":"1694_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R Package for comparing Biological themes among Gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"7","key":"1694_CR33","first-page":"790","volume":"1","author":"R Kolde","year":"2015","unstructured":"Kolde R, Kolde MR. Package \u2018pheatmap\u2019. R Package. 2015;1(7):790.","journal-title":"R Package"},{"issue":"6","key":"1694_CR34","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0031-9422(00)86904-6","volume":"35","author":"C Prakash Rao","year":"1994","unstructured":"Prakash Rao C, David Krupadanam GL. An isoflavan from Millettia racemosa. Phytochemistry. 1994;35(6):1597\u20139. https:\/\/doi.org\/10.1016\/S0031-9422(00)86904-6.","journal-title":"Phytochemistry"},{"issue":"17","key":"1694_CR35","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1080\/14786419.2019.1672068","volume":"35","author":"P Posri","year":"2019","unstructured":"Posri P, Suthiwong J, Thongsri Y, Yenjai C. Antifungal activity of compounds from the stems of Dalbergia stipulacea against Pythium Insidiosum. Nat Prod Res. 2019;35(17):2823\u201330. https:\/\/doi.org\/10.1080\/14786419.2019.1672068.","journal-title":"Nat Prod Res"},{"issue":"1","key":"1694_CR36","first-page":"8","volume":"53","author":"D-M Kang","year":"2022","unstructured":"Kang D-M, Park WS, Kim H-J, Jeong W-J. Kwon Kyoo Kang and Mi-Jeong Ahn. Anti-inflammatory constituents of Robinia pseudoacacia Root Bark. Korean J Pharmacognosy. 2022;53(1):8\u201315.","journal-title":"Korean J Pharmacognosy"},{"issue":"1","key":"1694_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0308-8146(00)00123-0","volume":"71","author":"W Wang","year":"2000","unstructured":"Wang W, Weng X, Cheng D. Antioxidant activities of natural phenolic components from Dalbergia Odorifera T. Chen. Food Chem. 2000;71(1):45\u2013. https:\/\/doi.org\/10.1016\/S0308-8146(00)00123-0. https:\/\/doi.org\/https:\/\/. \u20099.","journal-title":"Food Chem"},{"issue":"4","key":"1694_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/14786419.2016.1188094","volume":"31","author":"EE Shults","year":"2017","unstructured":"Shults EE, Shakirov MM, Pokrovsky MA, Petrova TN, Pokrovsky AG, Gorovoy PG. Phenolic compounds from Glycyrrhiza pallidiflora Maxim. And their cytotoxic activity. Nat Prod Res. 2017;31(4):445\u201352. https:\/\/doi.org\/10.1080\/14786419.2016.1188094.","journal-title":"Nat Prod Res"},{"issue":"2","key":"1694_CR39","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bmc.2009.11.027","volume":"18","author":"M Kuroda","year":"2010","unstructured":"Kuroda M, Mimaki Y, Honda S, Tanaka H, Yokota S, Mae T. Phenolics from Glycyrrhiza glabra roots and their PPAR-\u03b3 ligand-binding activity. Bioorg Med Chem. 2010;18(2):962\u201370. https:\/\/doi.org\/10.1016\/j.bmc.2009.11.027.","journal-title":"Bioorg Med Chem"},{"key":"1694_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bioorg.2019.03.041","volume":"87","author":"F Guo","year":"2019","unstructured":"Guo F, Zhang S, Yan X, Dan Y, Wang J, Zhao Y, et al. Bioassay-guided isolation of antioxidant and \u03b1-glucosidase inhibitory constituents from stem of Vigna angularis. Bioorg Chem. 2019;87:312\u201320. https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.041.","journal-title":"Bioorg Chem"},{"key":"1694_CR41","doi-asserted-by":"publisher","unstructured":"Zanr\u00e8 V, Campagnari R, Cerulli A, Masullo M, Cardile A, Piacente S, et al. Salviolone from Salvia miltiorrhiza roots impairs cell cycle progression, colony formation, and Metalloproteinase-2 activity in A375 Melanoma cells: involvement of P21(Cip1\/Waf1) expression and STAT3 phosphorylation. Int J Mol Sci. 2022;23(3). https:\/\/doi.org\/10.3390\/ijms23031121.","DOI":"10.3390\/ijms23031121"},{"issue":"6","key":"1694_CR42","first-page":"1739","volume":"23","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li G, Ji C. Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression. J buon. 2018;23(6):1739\u201344. G2\/M cell cycle arrest and downregulation of Nf-kB\/m-TOR\/PI3K\/AKT pathway.","journal-title":"J buon"},{"key":"1694_CR43","doi-asserted-by":"publisher","first-page":"e13148","DOI":"10.7717\/peerj.13148","volume":"10","author":"C Qin","year":"2022","unstructured":"Qin C, Wu M, Wang X, Zhang W, Qi G, Wu NY, et al. Study on the mechanism of Danshen-Guizhi drug pair in the treatment of ovarian cancer based on network pharmacology and in vitro experiment. PeerJ. 2022;10:e13148. https:\/\/doi.org\/10.7717\/peerj.13148.","journal-title":"PeerJ"},{"key":"1694_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14183","author":"X Wang","year":"2022","unstructured":"Wang X, Song R, Li Z. Salviolone protects against high glucose-induced proliferation, oxidative stress, inflammation and fibrosis of human renal mesangial cells by upregulating membrane metalloendopeptidase expression. Chem Biol Drug Des. 2022. https:\/\/doi.org\/10.1111\/cbdd.14183.","journal-title":"Chem Biol Drug Des"},{"key":"1694_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jep.2016.05.018","volume":"188","author":"S Ma","year":"2016","unstructured":"Ma S, Zhang D, Lou H, Sun L, Ji J. Evaluation of the anti-inflammatory activities of tanshinones isolated from Salvia miltiorrhiza var. Alba roots in THP-1 macrophages. J Ethnopharmacol. 2016;188:193\u20139. https:\/\/doi.org\/10.1016\/j.jep.2016.05.018.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1694_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molmed.2009.01.001","volume":"15","author":"I Bezprozvanny","year":"2009","unstructured":"Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol Med. 2009;15(3):89\u2013100. https:\/\/doi.org\/10.1016\/j.molmed.2009.01.001.","journal-title":"Trends Mol Med"},{"issue":"11","key":"1694_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","volume":"20","author":"M Kori","year":"2016","unstructured":"Kori M, Ayd\u0131n B, Unal S, Arga KY, Kazan D. Metabolic biomarkers and neurodegeneration: a pathway Enrichment Analysis of Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and amyotrophic lateral sclerosis. Omics. 2016;20(11):645\u201361. https:\/\/doi.org\/10.1089\/omi.2016.0106.","journal-title":"Omics"},{"issue":"Pt A","key":"1694_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","volume":"76","author":"R Anand","year":"2014","unstructured":"Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer\u2019s disease: past, present and future. Neuropharmacology. 2014;76(Pt A):27\u201350. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.07.004.","journal-title":"Neuropharmacology"},{"key":"1694_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jep.2016.11.034","volume":"196","author":"J Fang","year":"2017","unstructured":"Fang J, Wang L, Wu T, Yang C, Gao L, Cai H, et al. Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment. J Ethnopharmacol. 2017;196:281\u201392. https:\/\/doi.org\/10.1016\/j.jep.2016.11.034.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1694_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/en.2014-1675","volume":"156","author":"KM Heppner","year":"2015","unstructured":"Heppner KM, Kirigiti M, Secher A, Paulsen SJ, Buckingham R, Pyke C, et al. Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain. Endocrinology. 2015;156(1):255\u201367. https:\/\/doi.org\/10.1210\/en.2014-1675.","journal-title":"Endocrinology"},{"issue":"5","key":"1694_CR51","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today. 2016;21(5):802\u201318. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.013.","journal-title":"Drug Discov Today"},{"issue":"10","key":"1694_CR52","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","volume":"26","author":"C H\u00f6lscher","year":"2012","unstructured":"H\u00f6lscher C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs. 2012;26(10):871\u201382. https:\/\/doi.org\/10.2165\/11635890-000000000-00000.","journal-title":"CNS Drugs"},{"issue":"17","key":"1694_CR53","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1523\/jneurosci.0529-11.2011","volume":"31","author":"PL McClean","year":"2011","unstructured":"McClean PL, Parthsarathy V, Faivre E, H\u00f6lscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2011;31(17):6587\u201394. https:\/\/doi.org\/10.1523\/jneurosci.0529-11.2011.","journal-title":"J Neurosci"},{"key":"1694_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuropharm.2014.07.015","volume":"86","author":"PL McClean","year":"2014","unstructured":"McClean PL, H\u00f6lscher C. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer\u2019s disease. Neuropharmacology. 2014;86:241\u201358. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.07.015.","journal-title":"Neuropharmacology"},{"key":"1694_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2015.12.052","volume":"1634","author":"HH Hansen","year":"2016","unstructured":"Hansen HH, Barkholt P, Fabricius K, Jelsing J, Terwel D, Pyke C, et al. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy. Brain Res. 2016;1634:158\u201370. https:\/\/doi.org\/10.1016\/j.brainres.2015.12.052.","journal-title":"Brain Res"},{"key":"1694_CR56","doi-asserted-by":"publisher","unstructured":"Paladugu L, Gharaibeh A, Kolli N, Learman C, Hall TC, Li L, et al. Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22(2). https:\/\/doi.org\/10.3390\/ijms22020860.","DOI":"10.3390\/ijms22020860"},{"key":"1694_CR57","doi-asserted-by":"publisher","first-page":"114578","DOI":"10.1016\/j.bcp.2021.114578","volume":"188","author":"Y Xie","year":"2021","unstructured":"Xie Y, Zheng J, Li S, Li H, Zhou Y, Zheng W, et al. GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer\u2019s disease by regulating mitochondrial dysfunction via the cAMP\/PKA pathway. Biochem Pharmacol. 2021;188:114578. https:\/\/doi.org\/10.1016\/j.bcp.2021.114578.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1694_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1568007043482615","volume":"3","author":"J Bockaert","year":"2004","unstructured":"Bockaert J, Claeysen S, Compan V, Dumuis A. 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord. 2004;3(1):39\u201351. https:\/\/doi.org\/10.2174\/1568007043482615.","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"9","key":"1694_CR59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.tips.2008.07.001","volume":"29","author":"MV King","year":"2008","unstructured":"King MV, Marsden CA, Fone KC. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci. 2008;29(9):482\u201392. https:\/\/doi.org\/10.1016\/j.tips.2008.07.001.","journal-title":"Trends Pharmacol Sci"},{"key":"1694_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbr.2015.07.020","volume":"293","author":"A Quiedeville","year":"2015","unstructured":"Quiedeville A, Boulouard M, Hamidouche K, Da Silva Costa-Aze V, Nee G, Rochais C, et al. Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances. Behav Brain Res. 2015;293:10\u20137. https:\/\/doi.org\/10.1016\/j.bbr.2015.07.020.","journal-title":"Behav Brain Res"},{"key":"1694_CR61","doi-asserted-by":"publisher","unstructured":"Rebholz H, Friedman E, Castello J. Alterations of expression of the serotonin 5-HT4 receptor in Brain disorders. Int J Mol Sci. 2018;19(11). https:\/\/doi.org\/10.3390\/ijms19113581.","DOI":"10.3390\/ijms19113581"},{"issue":"36","key":"1694_CR62","doi-asserted-by":"publisher","first-page":"E3825","DOI":"10.1073\/pnas.1410315111","volume":"111","author":"C Lecoutey","year":"2014","unstructured":"Lecoutey C, Hedou D, Freret T, Giannoni P, Gaven F, Since M, et al. Design of donecopride, a dual serotonin subtype 4 receptor agonist\/acetylcholinesterase inhibitor with potential interest for Alzheimer\u2019s disease treatment. Proc Natl Acad Sci U S A. 2014;111(36):E3825\u201330. https:\/\/doi.org\/10.1073\/pnas.1410315111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR63","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuropharm.2017.08.031","volume":"126","author":"K Baranger","year":"2017","unstructured":"Baranger K, Giannoni P, Girard SD, Girot S, Gaven F, Stephan D, et al. Chronic treatments with a 5-HT(4) receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer\u2019s disease. Neuropharmacology. 2017;126:128\u201341. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.031.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1694_CR64","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0306-4522(90)90246-z","volume":"39","author":"KL Jansen","year":"1990","unstructured":"Jansen KL, Faull RL, Dragunow M, Synek BL. Alzheimer\u2019s disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors\u2013an autoradiographic study. Neuroscience. 1990;39(3):613\u201327. https:\/\/doi.org\/10.1016\/0306-4522(90)90246-z.","journal-title":"Neuroscience"},{"issue":"10","key":"1694_CR65","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.peptides.2006.03.036","volume":"27","author":"WB Rowe","year":"2006","unstructured":"Rowe WB, Kar S, Meaney MJ, Quirion R. Neurotensin receptor levels as a function of brain aging and cognitive performance in the Morris water maze task in the rat. Peptides. 2006;27(10):2415\u201323. https:\/\/doi.org\/10.1016\/j.peptides.2006.03.036.","journal-title":"Peptides"},{"issue":"20","key":"1694_CR66","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1523\/jneurosci.0408-14.2014","volume":"34","author":"Z Xiao","year":"2014","unstructured":"Xiao Z, Cilz NI, Kurada L, Hu B, Yang C, Wada E, et al. Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer\u2019s disease model. J Neurosci. 2014;34(20):7027\u201342. https:\/\/doi.org\/10.1523\/jneurosci.0408-14.2014.","journal-title":"J Neurosci"},{"issue":"6","key":"1694_CR67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1037\/a0037912","volume":"22","author":"AA Keiser","year":"2014","unstructured":"Keiser AA, Matazel KS, Esser MK, Feifel D, Prus AJ. Systemic administration of the neurotensin NTS\u2081-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats. Exp Clin Psychopharmacol. 2014;22(6):541\u20137. https:\/\/doi.org\/10.1037\/a0037912.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"1694_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/joe-20-0439","volume":"248","author":"N Saiyasit","year":"2021","unstructured":"Saiyasit N, Chunchai T, Jaiwongkam T, Kerdphoo S, Apaijai N, Pratchayasakul W, et al. Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats. J Endocrinol. 2021;248(1):59\u201374. https:\/\/doi.org\/10.1530\/joe-20-0439.","journal-title":"J Endocrinol"},{"issue":"10","key":"1694_CR69","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nm.1868","volume":"14","author":"H Du","year":"2008","unstructured":"Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease. Nat Med. 2008;14(10):1097\u2013105. https:\/\/doi.org\/10.1038\/nm.1868.","journal-title":"Nat Med"},{"issue":"1","key":"1694_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0896-6273(04)00182-5","volume":"42","author":"CA Saura","year":"2004","unstructured":"Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron. 2004;42(1):23\u201336. https:\/\/doi.org\/10.1016\/s0896-6273(04)00182-5.","journal-title":"Neuron"},{"issue":"1","key":"1694_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2005.8.3","volume":"8","author":"JJ Lemasters","year":"2005","unstructured":"Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005;8(1):3\u20135. https:\/\/doi.org\/10.1089\/rej.2005.8.3.","journal-title":"Rejuvenation Res"},{"issue":"1\u20132","key":"1694_CR72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jns.2007.01.017","volume":"257","author":"PI Moreira","year":"2007","unstructured":"Moreira PI, Santos MS, Sei\u00e7a R, Oliveira CR. Brain mitochondrial dysfunction as a link between Alzheimer\u2019s disease and diabetes. J Neurol Sci. 2007;257(1\u20132):206\u201314. https:\/\/doi.org\/10.1016\/j.jns.2007.01.017.","journal-title":"J Neurol Sci"},{"issue":"9","key":"1694_CR73","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","volume":"31","author":"I Bezprozvanny","year":"2008","unstructured":"Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease. Trends Neurosci. 2008;31(9):454\u201363. https:\/\/doi.org\/10.1016\/j.tins.2008.06.005.","journal-title":"Trends Neurosci"},{"issue":"1","key":"1694_CR74","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbadis.2009.07.005","volume":"1802","author":"H Du","year":"2010","unstructured":"Du H, Yan SS. Mitochondrial permeability transition pore in Alzheimer\u2019s disease: cyclophilin D and amyloid beta. Biochim Biophys Acta. 2010;1802(1):198\u2013204. https:\/\/doi.org\/10.1016\/j.bbadis.2009.07.005.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1694_CR75","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ceca.2012.03.001","volume":"52","author":"C C\u00e1rdenas","year":"2012","unstructured":"C\u00e1rdenas C, Foskett JK. Mitochondrial ca(2+) signals in autophagy. Cell Calcium. 2012;52(1):44\u201351. https:\/\/doi.org\/10.1016\/j.ceca.2012.03.001.","journal-title":"Cell Calcium"},{"issue":"6","key":"1694_CR76","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/jnr.20135","volume":"76","author":"E Ferreiro","year":"2004","unstructured":"Ferreiro E, Oliveira CR, Pereira C. Involvement of endoplasmic reticulum Ca2\u2009+\u2009release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J Neurosci Res. 2004;76(6):872\u201380. https:\/\/doi.org\/10.1002\/jnr.20135.","journal-title":"J Neurosci Res"},{"issue":"5","key":"1694_CR77","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.11.019","volume":"29","author":"I Dewachter","year":"2008","unstructured":"Dewachter I, Ris L, Croes S, Borghgraef P, Devijver H, Voets T, et al. Modulation of synaptic plasticity and tau phosphorylation by wild-type and mutant presenilin1. Neurobiol Aging. 2008;29(5):639\u201352. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.11.019.","journal-title":"Neurobiol Aging"},{"key":"1694_CR78","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","volume":"63","author":"DS Bredt","year":"1994","unstructured":"Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175\u201395. https:\/\/doi.org\/10.1146\/annurev.bi.63.070194.001135.","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"1694_CR79","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrendo.2017.69","volume":"13","author":"K Chachlaki","year":"2017","unstructured":"Chachlaki K, Garthwaite J, Prevot V. The gentle art of saying NO: how nitric oxide gets things done in the hypothalamus. Nat Rev Endocrinol. 2017;13(9):521\u201335. https:\/\/doi.org\/10.1038\/nrendo.2017.69.","journal-title":"Nat Rev Endocrinol"},{"issue":"24","key":"1694_CR80","doi-asserted-by":"publisher","first-page":"11285","DOI":"10.1073\/pnas.88.24.11285","volume":"88","author":"TJ O\u2019Dell","year":"1991","unstructured":"O\u2019Dell TJ, Hawkins RD, Kandel ER, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A. 1991;88(24):11285\u20139. https:\/\/doi.org\/10.1073\/pnas.88.24.11285.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1694_CR81","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2011.04.097","volume":"408","author":"SP Zoubovsky","year":"2011","unstructured":"Zoubovsky SP, Pogorelov VM, Taniguchi Y, Kim SH, Yoon P, Nwulia E, et al. Working memory deficits in neuronal nitric oxide synthase knockout mice: potential impairments in prefrontal cortex mediated cognitive function. Biochem Biophys Res Commun. 2011;408(4):707\u201312. https:\/\/doi.org\/10.1016\/j.bbrc.2011.04.097.","journal-title":"Biochem Biophys Res Commun"},{"key":"1694_CR82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/b978-0-12-800254-4.00006-4","volume":"96","author":"Y Hu","year":"2014","unstructured":"Hu Y, Zhu DY. Hippocampus and nitric oxide. Vitam Horm. 2014;96:127\u201360. https:\/\/doi.org\/10.1016\/b978-0-12-800254-4.00006-4.","journal-title":"Vitam Horm"},{"issue":"11","key":"1694_CR83","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.tins.2009.07.002","volume":"32","author":"S Jessberger","year":"2009","unstructured":"Jessberger S, Gage FH, Eisch AJ, Lagace DC. Making a neuron: Cdk5 in embryonic and adult neurogenesis. Trends Neurosci. 2009;32(11):575\u201382. https:\/\/doi.org\/10.1016\/j.tins.2009.07.002.","journal-title":"Trends Neurosci"},{"key":"1694_CR84","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuint.2016.06.005","volume":"99","author":"KJ Kwon","year":"2016","unstructured":"Kwon KJ, Park JH, Jo I, Song KH, Han JS, Park SH, et al. Disruption of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer\u2019s disease: involvement of cyclin-dependent kinase 5-mediated phosphorylation of neuronal nitric oxide synthase at ser(293). Neurochem Int. 2016;99:52\u201361. https:\/\/doi.org\/10.1016\/j.neuint.2016.06.005.","journal-title":"Neurochem Int"},{"issue":"4","key":"1694_CR85","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/acel.12473","volume":"15","author":"V Triaca","year":"2016","unstructured":"Triaca V, Sposato V, Bolasco G, Ciotti MT, Pelicci P, Bruni AC, et al. NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer\u2019s disease. Aging Cell. 2016;15(4):661\u201372. https:\/\/doi.org\/10.1111\/acel.12473.","journal-title":"Aging Cell"},{"key":"1694_CR86","doi-asserted-by":"publisher","unstructured":"Canu N, Amadoro G, Triaca V, Latina V, Sposato V, Corsetti V, et al. The Intersection of NGF\/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer\u2019s Disease Neuropathology. Int J Mol Sci. 2017;18(6). https:\/\/doi.org\/10.3390\/ijms18061319.","DOI":"10.3390\/ijms18061319"},{"issue":"7","key":"1694_CR87","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/glia.23312","volume":"66","author":"C Rizzi","year":"2018","unstructured":"Rizzi C, Tiberi A, Giustizieri M, Marrone MC, Gobbo F, Carucci NM, et al. NGF steers microglia toward a neuroprotective phenotype. Glia. 2018;66(7):1395\u2013416. https:\/\/doi.org\/10.1002\/glia.23312.","journal-title":"Glia"},{"key":"1694_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fncel.2017.00068","volume":"11","author":"V Latina","year":"2017","unstructured":"Latina V, Caioli S, Zona C, Ciotti MT, Amadoro G, Calissano P. Impaired NGF\/TrkA signaling causes early AD-Linked presynaptic dysfunction in Cholinergic primary neurons. Front Cell Neurosci. 2017;11:68. https:\/\/doi.org\/10.3389\/fncel.2017.00068.","journal-title":"Front Cell Neurosci"},{"key":"1694_CR89","doi-asserted-by":"publisher","first-page":"112488","DOI":"10.1016\/j.jep.2019.112488","volume":"251","author":"L Gu","year":"2020","unstructured":"Gu L, Lu J, Li Q, Wu N, Zhang L, Li H, et al. A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer\u2019s disease and experimental validation. J Ethnopharmacol. 2020;251:112488. https:\/\/doi.org\/10.1016\/j.jep.2019.112488.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"1694_CR90","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/cns.12697","volume":"23","author":"C Huang","year":"2017","unstructured":"Huang C, Dong D, Jiao Q, Pan H, Ma L, Wang R. Sarsasapogenin-AA13 ameliorates A\u03b2-induced cognitive deficits via improving neuroglial capacity on A\u03b2 clearance and antiinflammation. CNS Neurosci Ther. 2017;23(6):498\u2013509. https:\/\/doi.org\/10.1111\/cns.12697.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"1694_CR91","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/jad-221222","volume":"93","author":"M Singh","year":"2023","unstructured":"Singh M, Jindal D, Kumar R, Pancham P, Haider S, Gupta V, et al. Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) extract with dual target inhibitory mechanism in Alzheimer\u2019s Disease. J Alzheimers Dis. 2023;93(2):705\u201326. https:\/\/doi.org\/10.3233\/jad-221222.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1694_CR92","doi-asserted-by":"publisher","first-page":"19959","DOI":"10.1038\/s41598-022-24378-0","volume":"12","author":"D Qian","year":"2022","unstructured":"Qian D, Wang Q, Lin S, Li Y, Gu X, Xia C, et al. Identification of potential targets of cinnamon for treatment against Alzheimer\u2019s disease-related GABAergic synaptic dysfunction using network pharmacology. Sci Rep. 2022;12(1):19959. https:\/\/doi.org\/10.1038\/s41598-022-24378-0.","journal-title":"Sci Rep"},{"key":"1694_CR93","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejmech.2013.09.050","volume":"70","author":"M Singh","year":"2013","unstructured":"Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur J Med Chem. 2013;70:165\u201388. https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.050.","journal-title":"Eur J Med Chem"},{"issue":"1 Suppl 1","key":"1694_CR94","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.jalz.2007.11.013","volume":"4","author":"MN Sabbagh","year":"2008","unstructured":"Sabbagh MN, Richardson S, Relkin N. Disease-modifying approaches to Alzheimer\u2019s disease: challenges and opportunities-lessons from donepezil therapy. Alzheimers Dement. 2008;4(1 Suppl 1):S109\u201318. https:\/\/doi.org\/10.1016\/j.jalz.2007.11.013.","journal-title":"Alzheimers Dement"},{"issue":"23","key":"1694_CR95","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1111\/bph.14030","volume":"174","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer\u2019s disease. Br J Pharmacol. 2017;174(23):4224\u201332. https:\/\/doi.org\/10.1111\/bph.14030.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1694_CR96","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1517\/14740338.2014.914168","volume":"13","author":"F Zemek","year":"2014","unstructured":"Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, et al. Outcomes of Alzheimer\u2019s disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opin Drug Saf. 2014;13(6):759\u201374. https:\/\/doi.org\/10.1517\/14740338.2014.914168.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"1694_CR97","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"MB Colovic","year":"2013","unstructured":"Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315\u201335. https:\/\/doi.org\/10.2174\/1570159X11311030006.","journal-title":"Curr Neuropharmacol"},{"key":"1694_CR98","doi-asserted-by":"publisher","unstructured":"Rahman MH, Bajgai J, Fadriquela A, Sharma S, Trinh TT, Akter R, et al. Therapeutic potential of Natural products in treating neurodegenerative disorders and their future prospects and challenges. Molecules. 2021;26(17). https:\/\/doi.org\/10.3390\/molecules26175327.","DOI":"10.3390\/molecules26175327"},{"issue":"13","key":"1694_CR99","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1021\/jf0735073","volume":"56","author":"M Singh","year":"2008","unstructured":"Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer\u2019s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem. 2008;56(13):4855\u201373. https:\/\/doi.org\/10.1021\/jf0735073.","journal-title":"J Agric Food Chem"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01694-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01694-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01694-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T23:48:19Z","timestamp":1739576899000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01694-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01694-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Institutional Animal Ethics Committee, Capital Medical University, and complied with ethical regulations for animal research and testing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}